Literature Review on the Appropriateness of Medication Prescription in Chronic Kidney Disease Patients: Focus on Antibiotic Use
DOI:
https://doi.org/10.59188/eduvest.v5i3.44784Keywords:
chronic kidney disease, inappropriate prescription, antibiotics, dose adjustment, clinical outcome, adverse eventAbstract
Chronic Kidney Disease (CKD) significantly impacts pharmacokinetics and pharmacodynamics, altering drug metabolism and excretion, thus increasing the risk of drug toxicity. CKD patients are more susceptible to infections, which contribute to significant morbidity and mortality. This underscores the importance of appropriate antimicrobials used in this population. This literature review explores recent findings on medication prescribing practices, dose adjustments, and factors affecting appropriateness, especially in antibiotic use for CKD patients. A comprehensive literature search was conducted using six databases to identify studies published from 2015 to 2024. Twenty-six studies were included. This literature review found that prevalence of inappropriate prescriptions in CKD patients ranges widely between 10% to 77.1% and from 30% to 34,9% specifically for antibiotic, with higher rates observed in outpatient settings compared to hospital environments. Antibiotics, antidiabetic agents, antihypertensive, nutraceuticals, and electrolytes are frequently inappropriately prescribed. Factors influencing inappropriate prescription include comorbidity, severity level of kidney disorder, age, and polypharmacy. The antibiotics most commonly prescribed inappropriately include cefazolin, meropenem, oral sulfamethoxazole-trimethoprim, nebulised colistin, vancomycin, and piperacillin-tazobactam. This study emphasizes the mixed and limited evidence regarding the clinical outcomes of antibiotics dose adjustments in CKD patients. While some studies suggest that antibiotics dose adjustments improve therapeutic outcomes and reduce adverse events, others show no significant impact. Further research is needed to understand the impact of this intervention, as these outcomes may be influenced by various factors. Enhanced education and collaboration between healthcare providers are critical to improving the accuracy of antibiotic prescriptions and ensuring patient safety in CKD management.
References
Al Jasmi, S. M., Khan, A. H., Saadah, L. M., Sulaiman, S. A. S., & Al Khalidi, D. K. (2018). Concordance Among Methods for Empiric Renal Drug Dosing: Meropenem as a Role Model for Clinical Superiority of Cockroft–Gault or Modification of Diet in Renal Disease. Clinical Medicine Insights: Therapeutics, 10, 1179559X18777767.
Alqashqri, H. S., Siddiqi, A., Albar, H. T., Alfalogy, E. H., Hariri, N. H., Alhindi, Y. Z., Alshanberi, A. M., Alsanosi, S. M., & Falemban, A. H. (2024). Prescribing Renally Inappropriate Medication to Hospitalized Geriatric Patients in Makkah, Saudi Arabia. International Journal of General Medicine, 1755–1764.
Apata, I. W., Kabbani, S., Neu, A. M., Kear, T. M., D’Agata, E. M. C., Levenson, D. J., Kliger, A. S., Hicks, L. A., & Patel, P. R. (2021). Opportunities to improve antibiotic prescribing in outpatient hemodialysis facilities: a report from the American Society of Nephrology and Centers for Disease Control and Prevention Antibiotic Stewardship White Paper Writing Group. American Journal of Kidney Diseases, 77(5), 757–768.
Arcoraci, V., Barbieri, M. A., Rottura, M., Nobili, A., Natoli, G., Argano, C., Squadrito, G., Squadrito, F., Corrao, S., & Investigators, R. (2021). Kidney disease management in the hospital setting: a focus on inappropriate drug prescriptions in older patients. Frontiers in Pharmacology, 12, 749711.
Bello, A. K., Okpechi, I. G., Levin, A., Ye, F., Damster, S., Arruebo, S., Donner, J.-A., Caskey, F. J., Cho, Y., & Davids, M. R. (2024). An update on the global disparities in kidney disease burden and care across world countries and regions. The Lancet Global Health, 12(3), e382–e395.
Birarra, M. K., Mekonnen, G. B., Gelayee, D. A., Assimamaw, N. T., & Kifle, Z. D. (2022). Drug dose adjustment in patients with renal impairment attending a specialized referral hospital, Northwest Ethiopia. Metabolism Open, 16, 100211.
Castel-Branco, M. M., Lavrador, M., Cabral, A. C., Pinheiro, A., Fernandes, J., Figueiredo, I. V., & Fernandez-Llimos, F. (2024). Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study. International Journal of Clinical Pharmacy, 46(2), 411–420.
Clifford, K. M., Selby, A. R., Reveles, K. R., Teng, C., Hall 2nd, R. G., McCarrell, J., & Alvarez, C. A. (2022). The risk and clinical implications of antibiotic-associated acute kidney injury: a review of the clinical data for agents with signals from the food and drug administration’s adverse event reporting system (FAERS) database. Antibiotics, 11(10), 1367.
Cox, J. L. (2018). Renal function estimation equations and drug dosing: things are not always what they seem. The Canadian Journal of Cardiology, 34(8), 965–967.
Duval, X., Franck, B., Revest, M., Tron, C., Chemouny, J. M., Lalanne, S., Houot, R., Verdier, M.-C., & Lemaitre, F. (2022). Comparison of different equations for renal function evaluation as proxies for antibiotic drug clearance: The examples of amoxicillin and cloxacillin. Clinical Biochemistry, 109, 86–89.
Eyler, R. F., & Shvets, K. (2019). Clinical pharmacology of antibiotics. Clinical Journal of the American Society of Nephrology, 14(7), 1080–1090.
Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., & Nangaku, M. (2024). Chronic kidney disease and the global public health agenda: an international consensus. Nature Reviews Nephrology, 20(7), 473–485.
Hayat, M., Ahmad, N., Khan, S. L. A., Mohkumuddin, S., Siddique, W., Khan, A., & Atif, M. (2023). Pattern, frequency and factors associated with inappropriate high dosing in chronic kidney disease patients at a tertiary care hospital in Pakistan. BMC Nephrology, 24(1), 118.
Ishigami, J., & Matsushita, K. (2019). Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clinical and Experimental Nephrology, 23, 437–447.
Khanal, A., Peterson, G. M., Jose, M. D., & Castelino, R. L. (2017). Comparison of equations for dosing of medications in renal impairment. Nephrology, 22(6), 470–477.
Laville, S. M., Gras-Champel, V., Hamroun, A., Moragny, J., Lambert, O., Metzger, M., Jacquelinet, C., Combe, C., Fouque, D., & Laville, M. (2024). Kidney function decline and serious adverse drug reactions in patients with CKD. American Journal of Kidney Diseases, 83(5), 601–614.
Laville, S. M., Metzger, M., Stengel, B., Jacquelinet, C., Combe, C., Fouque, D., Laville, M., Frimat, L., Ayav, C., & Speyer, E. (2018). Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD‐REIN cohort. British Journal of Clinical Pharmacology, 84(12), 2811–2823.
Mirkov, S., Scuderi, C., Lloyd, J., Coutsouvelis, J., O’Connor, S., Potts, S., Newman, S., & Roberts, J. (2024). Estimation of kidney function for medication dosing in adult patients with chronic kidney disease: a practice update. Journal of Pharmacy Practice and Research, 54(1), 94–106.
Narayanan, M. (2019). The many faces of infection in CKD: evolving paradigms, insights, and novel therapies. Advances in Chronic Kidney Disease, 26(1), 5–7.
O’Shaughnessy, M., Allen, N., O’Regan, J., Payne-Danson, E., Mentre, L., Davin, D., Lavin, P., & Grimes, T. (2017). Agreement between renal prescribing references and determination of prescribing appropriateness in hospitalized patients with chronic kidney disease. QJM: An International Journal of Medicine, 110(10), 623–628.
Oosting, I. J., Colombijn, J. M. T., Kaasenbrood, L., Liabeuf, S., Laville, S. M., Hooft, L., Bots, M. L., Verhaar, M. C., & Vernooij, R. W. M. (2024). Polypharmacy in patients with chronic kidney disease. Kidney360, 10–34067.
Price, E. L., & Cotten, S. W. (2024). Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility. Clinics in Laboratory Medicine, 44(4), 705–717.
Ruiz-Boy, S., Rodriguez-Reyes, M., Clos-Soldevila, J., & Rovira-Illamola, M. (2022). Appropriateness of drug prescriptions in patients with chronic kidney disease in primary care: a double-center retrospective study. BMC Primary Care, 23(1), 323.
Sharma, A., Sahasrabudhe, V., Musib, L., Zhang, S., Younis, I., & Kanodia, J. (2022). Time to rethink the current paradigm for assessing kidney function in drug development and beyond. Clinical Pharmacology & Therapeutics, 112(5), 946–958.
Sönnerstam, E., Sjölander, M., & Gustafsson, M. (2016). Inappropriate prescription and renal function among older patients with cognitive impairment. Drugs & Aging, 33, 889–899.
Vondracek, S. F., Teitelbaum, I., & Kiser, T. H. (2021). Principles of kidney pharmacotherapy for the nephrologist: core curriculum 2021. American Journal of Kidney Diseases, 78(3), 442–458.
Yang, P., Chen, N., Wang, R.-R., Li, L., & Jiang, S.-P. (2016). Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital. Therapeutics and Clinical Risk Management, 1517–1524.
Zeleke, T. K., Kemal, L. K., Mehari, E. A., Sema, F. D., Seid, A. M., Mekonnen, G. A., & Abebe, R. B. (2024). Nephrotoxic drug burden and predictors of exposure among patients with renal impairment in Ethiopia: a multi-center study. Heliyon, 10(2).
Zilberman-Itskovich, S., Elukbi, Y., Weinberg Sibony, R., Shapiro, M., Zelnik Yovel, D., Strulovici, A., Khatib, A., & Marchaim, D. (2022). The epidemiology of multidrug-resistant sepsis among chronic hemodialysis patients. Antibiotics, 11(9), 1255.
Chen, J., Wang, S., Lu, L., Yang, Y., Wang, K., Zheng, J., Zhou, Z., Guo, P., Cai, Y., & Zhang, Q. (2024). Potentially inappropriate prescribing among older adults with hypertension in China: prevalence and related comorbidities across different outpatient settings. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1439230
MacRae, C., Mercer, S. W., Guthrie, B., & Henderson, D. (2021). Comorbidity in chronic kidney disease: A large cross-sectional study of prevalence in Scottish primary care. British Journal of General Practice, 71(704), E243–E249. https://doi.org/10.3399/bjgp20X714125
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ariesa Oktamauri, Nadia Farhanah Syafhan, Santi Purna Sari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
